TD Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$133M Sell
236,531
-31,319
-12% -$20.1M 0.11% 161
2025
Q4
$181M Sell
267,850
-36,340
-12% -$24.7M 0.15% 128
2025
Q3
$194M Sell
304,190
-25,321
-8% -$15.4M 0.16% 122
2025
Q2
$177M Buy
329,511
+35,798
+12% +$17.1M 0.15% 139
2025
Q1
$123M Buy
293,713
+19,908
+7% +$8.64M 0.11% 163
2024
Q4
$113M Sell
273,805
-20,907
-7% -$9.17M 0.1% 179
2024
Q3
$151M Sell
294,712
-15,421
-5% -$7.49M 0.13% 152
2024
Q2
$151M Sell
310,133
-1,834
-0.6% -$921K 0.14% 149
2024
Q1
$168M Buy
311,967
+51,959
+20% +$28.4M 0.16% 137
2023
Q4
$144M Buy
260,008
+166,751
+179% +$78.3M 0.14% 137
2023
Q3
$40.8M Sell
93,257
-1,769
-2% -$882K 0.05% 288
2023
Q2
$47.7M Buy
95,026
+42,281
+80% +$20.3M 0.05% 266
2023
Q1
$26.4M Buy
52,745
+516
+1% +$247K 0.03% 384
2022
Q4
$21.3M Buy
52,229
+3,616
+7% +$1.4M 0.03% 417
2022
Q3
$16.1M Buy
48,613
+342
+0.7% +$126K 0.02% 467
2022
Q2
$16.9M Sell
48,271
-1,626
-3% -$663K 0.02% 471
2022
Q1
$27.3M Buy
49,897
+1,435
+3% +$755K 0.03% 412
2021
Q4
$31.9M Sell
48,462
-40,531
-46% -$25.4M 0.03% 400
2021
Q3
$55.3M Sell
88,993
-228
-0.3% -$153K 0.06% 258
2021
Q2
$60.5M Sell
89,221
-7,845
-8% -$4.33M 0.06% 251
2021
Q1
$47.5M Sell
97,066
-11,319
-10% -$5.67M 0.05% 280
2020
Q4
$54.2M Sell
108,385
-7,925
-7% -$3.55M 0.07% 230
2020
Q3
$45.7M Buy
116,310
+9,624
+9% +$3.56M 0.06% 236
2020
Q2
$35.2M Buy
106,686
+4,619
+5% +$1.34M 0.05% 256
2020
Q1
$24.7M Buy
102,067
+14,635
+17% +$3.82M 0.04% 298
2019
Q4
$22.8M Buy
87,432
+5,737
+7% +$1.51M 0.03% 358
2019
Q3
$22.2M Buy
81,695
+287
+0.4% +$79.9K 0.03% 350
2019
Q2
$22.4M Sell
81,408
-1,738
-2% -$428K 0.03% 356
2019
Q1
$18.6M Buy
83,146
+7,651
+10% +$1.58M 0.03% 383
2018
Q4
$14M Sell
75,495
-2,512
-3% -$515K 0.02% 416
2018
Q3
$19.5M Sell
78,007
-12,638
-14% -$3.07M 0.03% 391
2018
Q2
$19.8M Buy
90,645
+21,233
+31% +$4.38M 0.03% 378
2018
Q1
$13.3M Buy
69,412
+9,739
+16% +$1.8M 0.02% 462
2017
Q4
$9.33M Buy
59,673
+15,578
+35% +$2.45M 0.01% 539
2017
Q3
$6.86M Sell
44,095
-1,704
-4% -$269K 0.01% 595
2017
Q2
$7.39M Sell
45,799
-27,126
-37% -$4.41M 0.01% 587
2017
Q1
$11.3M Buy
72,925
+25,820
+55% +$3.56M 0.02% 509
2016
Q4
$5.52M Sell
47,105
-995
-2% -$114K 0.01% 658
2016
Q3
$5.42M Buy
48,100
+1,200
+3% +$126K 0.01% 681
2016
Q2
$4.36M Sell
46,900
-100
-0.2% -$8.59K 0.01% 717
2016
Q1
$3.68M Sell
47,000
-67,300
-59% -$4.85M 0.01% 742
2015
Q4
$8.34M Sell
114,300
-16,100
-12% -$1.15M 0.02% 523
2015
Q3
$9.68M Buy
130,400
+4,200
+3% +$301K 0.02% 472
2015
Q2
$8.09M Sell
126,200
-600
-0.5% -$41.5K 0.01% 557
2015
Q1
$9.79M Sell
126,800
-7,200
-5% -$560K 0.02% 500
2014
Q4
$9.93M Sell
134,000
-16,800
-11% -$1.18M 0.02% 489
2014
Q3
$8.88M Sell
150,800
-34,600
-19% -$2.19M 0.02% 494
2014
Q2
$12.4M Sell
185,400
-1,400
-0.7% -$89K 0.02% 430
2014
Q1
$11.3M Buy
186,800
+15,000
+9% +$894K 0.02% 435
2013
Q4
$9.14M Buy
171,800
+1,600
+0.9% +$84.2K 0.02% 470
2013
Q3
$8.48M Buy
170,200
+8,200
+5% +$394K 0.02% 467
2013
Q2
$7.27M Buy
+162,000
New +$7.08M 0.02% 489

Other funds holding IDXX

TD Asset Management's IDXX Position: Q1 2026 in Review

TD Asset Management reduced its Idexx Laboratories (IDXX) stake by 12% in Q1 2026, selling an estimated $20.1M and leaving 236,531 shares worth $133M. The position accounts for 0.11% of the portfolio, ranked #161.

TD Asset Management first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $194M in Q3 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • TD Asset Management held 236,531 shares of Idexx Laboratories worth $133M as of Q1 2026.
  • TD Asset Management sold 31,319 Idexx Laboratories shares in Q1 2026, an estimated $20.1M.
  • Idexx Laboratories made up 0.11% of TD Asset Management's portfolio in Q1 2026, its #161 holding.
  • TD Asset Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • TD Asset Management's Idexx Laboratories position peaked at $194M in Q3 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.